Icon PLC (ICLR): Share Repurchases
$750.00M
Year ended 2025-12-31
+95.8%
3-year compound annual growth
+33.8%
5-year compound annual growth
+5.1%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $750.00M | +50.0% | 2026-05-27, From 2025-01-01 |
| 2024-12-31 | $500.00M | n/a | 2026-05-27, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2026-05-27, From 2023-01-01 |
| 2022-12-31 | $99.98M | n/a | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $0 | -100.0% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $175.00M | +19.1% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $146.93M | +13.9% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $128.96M | -3.1% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $133.11M | +21.0% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $110.00M | -76.0% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $457.89M | +227.0% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $140.03M | n/a | 2017-02-28, From 2014-01-01 |
| No annual figure between 2012-12-31 and 2014-12-31. | |||
| 2012-12-31 | $15.61M | +73.3% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $9.01M | n/a | 2014-03-12, From 2011-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $750.00M | +50.0% |
| Incyte Corp (INCY) | 2025-12-31 | $0 | -100.0% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.24B | -7.9% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $360.67M | +202.6% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $917.39M | +440.1% |
| NRC Health (NRC) | 2025-12-31 | $20.18M | -34.8% |
| IB Acquisition Corp. (IBAC) | 2025-09-30 | $106.13M | n/a |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗